Skip to main content
. Author manuscript; available in PMC: 2019 Mar 13.
Published in final edited form as: Cerebrovasc Dis. 2018 Mar 13;45(3-4):93–100. doi: 10.1159/000487406

Figure 2.

Figure 2

Baseline ADCr of ≥ 64% is associated with improved 90-day outcome. Higher baseline ADCr was associated with a shift in overall mRS (p = 0.028). Additionally, a greater proportion of patients with baseline ADCr < 64% were severely disabled or dead at 90 days (mRS 5–6, 52.2% with ADCr < 64% vs 19.1% with ADCr ≥ 64%, p = 0.006).